Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2010

Options

30 April 201324 December 2010 by Karen Mobbs

Options

Categories 2010

Biotron Limited Security Trading Policy

30 April 201323 December 2010 by Karen Mobbs

Biotron Limited Security Trading Policy

Categories 2010

Results of Annual General Meeting

30 April 201326 November 2010 by Karen Mobbs

Results of Annual General Meeting

Categories 2010

International Study Supports Biotron’s HIV Drug Approach

30 April 201325 November 2010 by Karen Mobbs

International Study Supports Biotron’s HIV Drug Approach

Categories 2010

Presentation to investors

4 March 201411 November 2010 by Karen Mobbs

Presentation to investors

Categories 2010, ASX Announcements

Quarterly Report 30 September 2010

30 April 201327 October 2010 by Karen Mobbs

Quarterly Report 30 September 2010

Categories 2010, Quarterly Reports

Annual Report for year ended 30 June 2010 and Notice of Annual General Meeting

30 April 201327 October 2010 by Karen Mobbs

Annual Report for year ended 30 June 2010 and Notice of Annual General Meeting

Categories 2010

Presentation to investors

4 March 201420 October 2010 by Karen Mobbs

Presentation to investors

Categories 2010, ASX Announcements

October edition of BITNews

28 April 201314 October 2010 by Karen Mobbs

October 2010 edition of BITNews

Categories 2010, ASX Announcements, Newsletters

Phase II HCV Clinical Trial Commenced

30 April 20131 October 2010 by Karen Mobbs

Phase II HCV Clinical Trial Commenced

Categories 2010
Older posts
Page1 Page2 Page3 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 24 April 2025        Legal Notices and Privacy
Cleantalk Pixel